8-KOther EventsExhibits & Filings

ENTEGRIS INC 8-K Report, Corporate Update (Apr 8, 2019)

Filed April 8, 2019For Securities:ENTG

Summary

Entegris, Inc. (ENTG) filed an 8-K on April 8, 2019, to disclose an important development regarding its proposed merger with Versum Materials, Inc. The Board of Directors of Versum Materials has determined that a revised proposal from Merck KGaA constitutes a "Superior Proposal" relative to the existing merger agreement with Entegris. This announcement indicates a significant challenge to Entegris's acquisition of Versum and suggests that Merck KGaA's offer may be more attractive to Versum shareholders. This filing serves as a notification to investors about the evolving M&A landscape for Versum Materials. It highlights that the previously agreed-upon merger terms between Entegris and Versum are now facing superior competition. Investors should closely monitor any further developments, including Entegris's potential response, any counter-offers, and the ultimate decision of Versum's board and shareholders, as this could materially impact the future of both companies and the semiconductor materials industry.

Key Highlights

  • 1Versum Materials' Board of Directors has identified Merck KGaA's revised proposal as a "Superior Proposal" in the context of its merger agreement with Entegris.
  • 2This determination by Versum's board directly challenges Entegris's proposed acquisition of Versum.
  • 3The filing incorporates by reference a press release dated April 8, 2019, detailing this development.
  • 4Entegris previously entered into an Agreement and Plan of Merger with Versum on January 27, 2019.
  • 5The company reiterates detailed forward-looking statements and risk factors associated with the proposed transaction and general business operations.
  • 6Investors are urged to read the definitive joint proxy statement/prospectus and other SEC filings for comprehensive information on the proposed transaction.

Frequently Asked Questions

A "Superior Proposal" generally means that another offer (in this case, from Merck KGaA) is deemed more favorable by the target company's board of directors compared to the existing merger agreement (with Entegris), considering factors like price, terms, and likelihood of completion.

The filing does not explicitly state Entegris's response. However, in such situations, Entegris may choose to negotiate improved terms with Versum, let the deal lapse, or potentially make a competing offer to counter Merck KGaA. The company's strategic options will depend on its assessment of the situation and its own business objectives.

This development significantly complicates the proposed merger between Entegris and Versum. It introduces uncertainty and suggests that the transaction, as originally agreed upon, may not proceed if Versum accepts Merck KGaA's superior offer. Investors should watch for any amendments to the merger agreement or further announcements from either company.

Investors are strongly encouraged to read the definitive joint proxy statement/prospectus filed by Entegris and Versum, as well as other filings with the SEC. These documents contain important information about the proposed transaction, risks, and details on how to access them via the SEC website or the companies' investor relations pages.